MS severity correlates with the number of active CD4+ T cells found in acute lesions, and IFN-γ, IL-2, and TNF-α are elevated in the blood of patients with MS (Bai et al., 2019; Chitnis, 2007; Peeters et al., 2017). This evidence concerns the gene IL2 and myeloid sarcoma.